Marília Berlofa Visacri

Colistin and polymyxin B for treatment of nosocomial infections in intensive care unit patients: pharmacoeconomic analysis

Júlia C.F. Quintanilha, N Duarte, Gustavo Rafaini Lloret et al. · International Journal of Clinical Pharmacy · 2018 · 38 citations · Full text

Pharmacoeconomic Analysis, Antimicrobial Stewardship, Healthcare-associated Infection +8

Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients

Guilherme Nogueira, Ericka Francislaine Dias Costa, Leisa Lopes‐Aguiar et al. · Oncotarget · 2018 · 36 citations · Full text

Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection

Priscila Gava Mazzola, Caroline Costa, Renata Carnevale et al. · Therapeutics and Clinical Risk Management · 2014 · 35 citations · Full text

Can acetylcysteine ameliorate cisplatin‐induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double‐blind, placebo‐controlled trial involving patients with head and neck cancer

Marília Berlofa Visacri, Júlia C.F. Quintanilha, Vanessa Marcílio de Sousa et al. · Cancer Medicine · 2019 · 34 citations · Full text

Protective Antioxidant Activity, Neck Cancer, Oncology +14

Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study

Marília Berlofa Visacri, Eder de Carvalho Pincinato, G. Ferrari et al. · DARU Journal of Pharmaceutical Sciences · 2017 · 29 citations · Full text